Advertisement
Screener

PERSPECTIVE THERAPEUTICS, INC. (CATX) Operating Expenses

PERSPECTIVE THERAPEUTICS, INC. Operating Expenses

PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Operating Expenses of $29.34 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2026-08-10

  • PERSPECTIVE THERAPEUTICS, INC. operating expenses for the quarter ending 2026-06-30 was $29.34M, a 20.59% increase year-over-year.
  • PERSPECTIVE THERAPEUTICS, INC. operating expenses for the quarter ending 2026-03-31 was $28.36M, a 27.88% increase year-over-year.
  • PERSPECTIVE THERAPEUTICS, INC. operating expenses for the quarter ending 2025-12-31 was $39.88M, a 11.82% decline year-over-year.
  • PERSPECTIVE THERAPEUTICS, INC. operating expenses for the quarter ending 2025-09-30 was $28.07M, a 47.71% increase year-over-year.
  • PERSPECTIVE THERAPEUTICS, INC. operating expenses for fiscal 2025 was $114.45M, a 23.94% increase from fiscal 2024.
  • PERSPECTIVE THERAPEUTICS, INC. operating expenses for fiscal 2024 was $92.34M, a 117.91% increase from fiscal 2023.
  • PERSPECTIVE THERAPEUTICS, INC. operating expenses for fiscal 2023 was $42.38M, a 388.64% increase from fiscal 2022.
  • PERSPECTIVE THERAPEUTICS, INC. operating expenses for fiscal 2022 was $8.67M.
Period endOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 6 monthOperating Expenses 6 month as first filedOperating Expenses 9 monthOperating Expenses 9 month as first filedOperating Expenses 12 monthOperating Expenses 12 month as first filed
2026-06-30$29.34M
10-Q · filed 2026-08-10
$57.70M
10-Q · filed 2026-08-10
$97.57M
derived: sum of 3 quarters · filed 2026-08-10
$125.64M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31$28.36M
10-Q · filed 2026-05-11
$68.23M
derived: sum of 2 quarters · filed 2026-05-11
$96.30M
derived: sum of 3 quarters · filed 2026-05-11
$120.63M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31$39.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$67.94M
derived: sum of 2 quarters · filed 2026-03-16
$92.27M
derived: sum of 3 quarters · filed 2026-08-10
$114.45M
10-K · filed 2026-03-16
2025-09-30$28.07M
10-Q · filed 2025-11-10
$52.40M
derived: sum of 2 quarters · filed 2026-08-10
$74.57M
10-Q · filed 2025-11-10
$119.79M
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30$24.33M
10-Q · filed 2026-08-10
$46.50M
10-Q · filed 2026-08-10
$91.72M
derived: sum of 3 quarters · filed 2026-08-10
$110.72M
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31$22.17M
10-Q · filed 2026-05-11
$67.39M
derived: sum of 2 quarters · filed 2026-05-11
$86.39M
derived: sum of 3 quarters · filed 2026-05-11
$101.18M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31$45.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$64.22M
derived: sum of 2 quarters · filed 2026-03-16
$79.01M
derived: sum of 3 quarters · filed 2026-03-16
$92.34M
10-K · filed 2026-03-16
2024-09-30$19.00M
10-Q · filed 2025-11-10
$33.79M
derived: sum of 2 quarters · filed 2025-11-10
$47.12M
10-Q · filed 2025-11-10
$59.13M
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30$14.79M
10-Q · filed 2025-08-13
$28.12M
10-Q · filed 2025-08-13
$40.13M
derived: sum of 3 quarters · filed 2025-08-13
$50.16M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$13.33M
10-Q · filed 2025-05-12
$25.34M
derived: sum of 2 quarters · filed 2025-05-12
$35.37M
derived: sum of 3 quarters · filed 2025-05-12
$45.71M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31$12.01M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-03-28
$22.04M
derived: sum of 2 quarters · filed 2025-03-28
$32.38M
derived: sum of 3 quarters · filed 2025-03-28
$42.38M
10-K/A · filed 2025-03-28
2023-09-30$10.03M
10-Q · filed 2024-11-12
$11.27M
10-Q · filed 2023-11-14
$20.37M
derived: sum of 2 quarters · filed 2024-11-12
$30.36M
10-Q · filed 2024-11-12
$34.61M
10-Q · filed 2023-11-14
$31.36M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$10.34M
10-Q · filed 2024-08-13
$11.62M
10-Q · filed 2023-08-11
$20.34M
10-Q · filed 2024-08-13
$23.34M
10-Q · filed 2023-08-11
$21.34M
derived: sum of 3 quarters · filed 2024-08-13
$25.96M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$9.99M
10-Q · filed 2024-05-15
$11.71M
10-Q · filed 2023-05-15
$10.99M
derived: sum of 2 quarters · filed 2024-05-15
$15.62M
derived: sum of 3 quarters · filed 2024-05-15
$18.65M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$999.00K
derived: 10-K 6 month − 10-Q 3 month · filed 2024-03-28
$5.62M
10-K · filed 2024-03-28
$8.71M
10-KT · filed 2023-05-01
$8.65M
derived: sum of 3 quarters · filed 2024-03-28
$8.67M
10-K · filed 2024-03-28
2022-09-30$4.62M
10-Q · filed 2023-11-14
$7.65M
derived: sum of 2 quarters · filed 2023-11-14
$10.47M
10-Q · filed 2023-11-14
$13.33M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$3.03M
10-Q · filed 2023-08-11
$5.85M
10-Q · filed 2023-08-11
$8.70M
derived: sum of 3 quarters · filed 2023-08-11
$6.42M
10-K · filed 2024-03-28
$12.01M
10-K · filed 2022-09-28
2022-03-31$2.82M
10-Q · filed 2023-05-15
$5.67M
derived: sum of 2 quarters · filed 2023-05-15
$8.97M
10-Q · filed 2022-05-13
$11.41M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$2.85M
10-Q · filed 2022-02-09
$6.16M
10-KT · filed 2023-05-01
$8.60M
derived: sum of 3 quarters · filed 2023-05-01
$10.72M
derived: sum of 4 quarters · filed 2023-05-01
2021-09-30$3.30M
10-Q · filed 2022-11-14
$5.74M
derived: sum of 2 quarters · filed 2023-05-01
$7.87M
derived: sum of 3 quarters · filed 2023-05-01
$9.91M
derived: sum of 4 quarters · filed 2023-05-01
2021-06-30$2.44M
derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01
$4.57M
derived: sum of 2 quarters · filed 2023-05-01
$6.61M
derived: sum of 3 quarters · filed 2023-05-01
$8.57M
10-KT · filed 2023-05-01
2021-03-31$2.13M
10-Q · filed 2022-05-13
$4.17M
derived: sum of 2 quarters · filed 2022-05-13
$6.13M
10-Q · filed 2022-05-13
$8.39M
derived: sum of 4 quarters · filed 2023-05-01
2020-12-31$2.04M
10-Q · filed 2022-02-09
$4.00M
10-Q · filed 2022-02-09
$6.26M
derived: sum of 3 quarters · filed 2023-05-01
$8.51M
derived: sum of 4 quarters · filed 2023-05-01
2020-09-30$1.96M
10-Q · filed 2021-11-10
$4.22M
derived: sum of 2 quarters · filed 2023-05-01
$6.47M
derived: sum of 3 quarters · filed 2023-05-01
$8.49M
derived: sum of 4 quarters · filed 2023-05-01
2020-06-30$2.26M
derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01
$4.51M
derived: sum of 2 quarters · filed 2023-05-01
$6.53M
derived: sum of 3 quarters · filed 2023-05-01
$8.60M
10-KT · filed 2023-05-01
2020-03-31$2.25M
10-Q · filed 2021-05-14
$4.27M
derived: sum of 2 quarters · filed 2021-05-14
$6.34M
10-Q · filed 2021-05-14
$8.36M
derived: sum of 4 quarters · filed 2021-09-27
2019-12-31$2.01M
10-Q · filed 2021-02-09
$4.09M
10-Q · filed 2021-02-09
$6.11M
derived: sum of 3 quarters · filed 2021-09-27
$8.15M
derived: sum of 4 quarters · filed 2021-09-27
2019-09-30$2.07M
10-Q · filed 2020-11-13
$4.09M
derived: sum of 2 quarters · filed 2021-09-27
$6.14M
derived: sum of 3 quarters · filed 2021-09-27
$8.33M
derived: sum of 4 quarters · filed 2021-09-27
2019-06-30$2.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-27
$4.07M
derived: sum of 2 quarters · filed 2021-09-27
$6.26M
derived: sum of 3 quarters · filed 2021-09-27
$8.30M
10-K · filed 2021-09-27
2019-03-31$2.04M
10-Q · filed 2020-05-13
$4.24M
derived: sum of 2 quarters · filed 2020-05-13
$6.28M
10-Q · filed 2020-05-13
$9.09M
derived: sum of 4 quarters · filed 2020-09-25
2018-12-31$2.19M
10-Q · filed 2020-02-12
$4.24M
10-Q · filed 2020-02-12
$7.04M
derived: sum of 3 quarters · filed 2020-09-25
$8.99M
derived: sum of 4 quarters · filed 2020-09-25
2018-09-30$2.04M
10-Q · filed 2019-11-13
$4.85M
derived: sum of 2 quarters · filed 2020-09-25
$6.80M
derived: sum of 3 quarters · filed 2020-09-25
$8.80M
derived: sum of 4 quarters · filed 2020-09-25
2018-06-30$2.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25
$4.75M
derived: sum of 2 quarters · filed 2020-09-25
$6.75M
derived: sum of 3 quarters · filed 2020-09-25
$8.57M
10-K · filed 2020-09-25
2018-03-31$1.95M
10-Q · filed 2019-05-10
$3.95M
derived: sum of 2 quarters · filed 2019-05-10
$5.76M
10-Q · filed 2019-05-10
$8.13M
derived: sum of 4 quarters · filed 2019-09-27
2017-12-31$2.00M
10-Q · filed 2019-02-13
$3.82M
10-Q · filed 2019-02-13
$6.18M
derived: sum of 3 quarters · filed 2019-09-27
$7.86M
derived: sum of 4 quarters · filed 2019-09-27
2017-09-30$1.82M
10-Q · filed 2018-11-09
$4.18M
derived: sum of 2 quarters · filed 2019-09-27
$5.86M
derived: sum of 3 quarters · filed 2019-09-27
$7.34M
derived: sum of 4 quarters · filed 2019-09-27
2017-06-30$2.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27
$4.04M
derived: sum of 2 quarters · filed 2019-09-27
$5.52M
derived: sum of 3 quarters · filed 2019-09-27
$7.14M
10-K · filed 2019-09-27
2017-03-31$1.68M
10-Q · filed 2018-05-04
$3.16M
derived: sum of 2 quarters · filed 2018-05-04
$4.78M
10-Q · filed 2018-05-04
$5.99M
derived: sum of 4 quarters · filed 2018-09-26
2016-12-31$1.48M
10-Q · filed 2018-02-09
$3.10M
10-Q · filed 2018-02-09
$4.31M
derived: sum of 3 quarters · filed 2018-09-26
$5.70M
derived: sum of 4 quarters · filed 2018-09-26
2016-09-30$1.62M
10-Q · filed 2017-11-14
$2.83M
derived: sum of 2 quarters · filed 2018-09-26
$4.22M
derived: sum of 3 quarters · filed 2018-09-26
$5.66M
derived: sum of 4 quarters · filed 2018-09-26
2016-06-30$1.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-26
$2.60M
derived: sum of 2 quarters · filed 2018-09-26
$4.04M
derived: sum of 3 quarters · filed 2018-09-26
$5.21M
10-K · filed 2018-09-26
$5.21M
10-K · filed 2016-09-09
2016-03-31$1.39M
10-Q · filed 2017-05-10
$1.39M
10-Q · filed 2016-05-10
$2.83M
derived: sum of 2 quarters · filed 2017-05-10
$4.00M
10-Q · filed 2017-05-10
$4.00M
10-Q · filed 2016-05-10
$5.31M
derived: sum of 4 quarters · filed 2017-09-28
2015-12-31$1.44M
10-Q · filed 2017-02-09
$1.44M
10-Q · filed 2016-02-09
$2.61M
10-Q · filed 2017-02-09
$2.61M
10-Q · filed 2016-02-09
$3.92M
derived: sum of 3 quarters · filed 2017-09-28
$5.03M
derived: sum of 4 quarters · filed 2017-09-28
2015-09-30$1.17M
10-Q · filed 2016-11-09
$1.17M
10-Q · filed 2015-11-09
$2.48M
derived: sum of 2 quarters · filed 2017-09-28
$3.59M
derived: sum of 3 quarters · filed 2017-09-28
$4.57M
derived: sum of 4 quarters · filed 2017-09-28
2015-06-30$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28
$2.42M
derived: sum of 2 quarters · filed 2017-09-28
$3.40M
derived: sum of 3 quarters · filed 2017-09-28
$4.50M
10-K · filed 2017-09-28
$4.50M
10-K · filed 2015-09-14
2015-03-31$1.11M
10-Q · filed 2016-05-10
$2.09M
derived: sum of 2 quarters · filed 2016-05-10
$3.19M
10-Q · filed 2016-05-10
$4.38M
derived: sum of 4 quarters · filed 2016-09-09
2014-12-31$982.35K
10-Q · filed 2016-02-09
$2.09M
10-Q · filed 2016-02-09
$3.27M
derived: sum of 3 quarters · filed 2016-09-09
$4.31M
derived: sum of 4 quarters · filed 2016-09-09
2014-09-30$1.11M
10-Q · filed 2015-11-09
$2.29M
derived: sum of 2 quarters · filed 2016-09-09
$3.33M
derived: sum of 3 quarters · filed 2016-09-09
$4.34M
derived: sum of 4 quarters · filed 2016-09-09
2014-06-30$1.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-09
$2.22M
derived: sum of 2 quarters · filed 2016-09-09
$3.23M
derived: sum of 3 quarters · filed 2016-09-09
$4.39M
10-K · filed 2016-09-09
2014-03-31$1.04M
10-Q · filed 2015-05-15
$2.05M
derived: sum of 2 quarters · filed 2015-05-15
$3.21M
10-Q · filed 2015-05-15
$4.37M
derived: sum of 4 quarters · filed 2015-09-14
2013-12-31$1.01M
10-Q · filed 2015-02-17
$2.17M
10-Q · filed 2015-02-17
$3.33M
derived: sum of 3 quarters · filed 2015-09-14
$4.34M
derived: sum of 4 quarters · filed 2015-09-14
2013-09-30$1.16M
10-Q · filed 2014-11-14
$2.32M
derived: sum of 2 quarters · filed 2015-09-14
$3.33M
derived: sum of 3 quarters · filed 2015-09-14
$4.27M
derived: sum of 4 quarters · filed 2015-09-14
2013-06-30$1.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14
$2.17M
derived: sum of 2 quarters · filed 2015-09-14
$3.12M
derived: sum of 3 quarters · filed 2015-09-14
$4.22M
10-K · filed 2015-09-14
2013-03-31$1.01M
10-Q · filed 2014-05-15
$1.95M
derived: sum of 2 quarters · filed 2014-05-15
$3.05M
10-Q · filed 2014-05-15
$4.23M
derived: sum of 4 quarters · filed 2014-05-15
2012-12-31$940.83K
10-Q · filed 2014-02-14
$2.04M
10-Q · filed 2014-02-14
$3.22M
derived: sum of 3 quarters · filed 2014-02-14
$4.18M
derived: sum of 4 quarters · filed 2014-02-14
2012-09-30$1.10M
10-Q · filed 2013-11-14
$2.28M
derived: sum of 2 quarters · filed 2013-11-14
$3.24M
derived: sum of 3 quarters · filed 2013-11-14
$4.23M
derived: sum of 4 quarters · filed 2013-11-14
2012-06-30$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-30
$2.14M
derived: sum of 2 quarters · filed 2013-09-30
$3.13M
derived: sum of 3 quarters · filed 2013-09-30
$4.30M
10-K · filed 2013-09-30
2012-03-31$967.08K
10-Q · filed 2013-05-15
$1.96M
derived: sum of 2 quarters · filed 2013-05-15
$3.13M
10-Q · filed 2013-05-15
$4.35M
derived: sum of 4 quarters · filed 2013-05-15
2011-12-31$990.95K
10-Q · filed 2013-02-14
$2.16M
10-Q · filed 2013-02-14
$3.38M
derived: sum of 3 quarters · filed 2013-02-14
$4.43M
derived: sum of 4 quarters · filed 2013-02-14
2011-09-30$1.17M
10-Q · filed 2012-11-14
$2.39M
derived: sum of 2 quarters · filed 2012-11-14
$3.44M
derived: sum of 3 quarters · filed 2012-11-14
$4.20M
derived: sum of 4 quarters · filed 2012-11-14
2011-06-30$1.22M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26
$2.27M
derived: sum of 2 quarters · filed 2012-10-26
$3.04M
derived: sum of 3 quarters · filed 2012-10-26
$4.12M
10-K/A · filed 2012-10-26
2011-03-31$1.05M
10-Q · filed 2012-05-15
$1.81M
derived: sum of 2 quarters · filed 2012-05-15
$2.90M
10-Q · filed 2012-05-15
2010-12-31$762.55K
10-Q · filed 2012-02-14
$1.85M
10-Q · filed 2012-02-14
2010-09-30$1.08M
10-Q/A · filed 2011-12-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58